Subclinical central hypothyroidism in patients with hypothalamic-pituitary disease: does it exist?

Area of Science:

• Endocrinology
• Cardiology
• Diagnostic Biomarkers

Background:

• Central hypothyroidism (CH) results from insufficient TSH stimulation of the thyroid gland.
• Current diagnosis relies on low FT4, which has low sensitivity for CH.
• Cardiac time intervals, like isovolumic contraction time (ICT), reflect peripheral thyroid hormone action.

Purpose of the Study:

• To investigate the prevalence and diagnosis of subclinical CH in patients with hypothalamic-pituitary disease.
• To evaluate the utility of cardiac time intervals as a diagnostic biomarker for subclinical CH.
• To challenge the interpretation of normal FT4 levels in excluding CH.

Main Methods:

• Utilized Doppler echocardiography to measure cardiac time intervals, specifically ICT.
• Analyzed ICT in patients with hypothalamic-pituitary disease and varying FT4 levels.
• Assessed changes in ICT following thyroxine replacement therapy.

Main Results:

• A high proportion of patients with hypothalamic-pituitary disease and normal FT4 levels exhibited prolonged ICT.
• ICT normalized with thyroxine treatment, confirming its role as a biomarker.
• Findings suggest subclinical CH is frequent in this population, even with mid-range FT4.

Conclusions:

• Subclinical CH is prevalent in patients with hypothalamic-pituitary disease and normal FT4 levels.
• Prolonged ICT is a reliable diagnostic biomarker for subclinical CH.
• Doppler echocardiography can improve diagnosis and monitoring of CH, potentially reducing cardiovascular risk.